Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2003-7-8
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1526-632X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
8
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
141-2
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12847181-Adenosine Triphosphate, pubmed-meshheading:12847181-Aspartic Acid, pubmed-meshheading:12847181-Brain, pubmed-meshheading:12847181-Choline, pubmed-meshheading:12847181-Creatine, pubmed-meshheading:12847181-Diarrhea, pubmed-meshheading:12847181-Dietary Supplements, pubmed-meshheading:12847181-Dose-Response Relationship, Drug, pubmed-meshheading:12847181-Humans, pubmed-meshheading:12847181-Huntington Disease, pubmed-meshheading:12847181-Magnetic Resonance Spectroscopy, pubmed-meshheading:12847181-Muscle, Skeletal, pubmed-meshheading:12847181-Nausea, pubmed-meshheading:12847181-Neuropsychological Tests, pubmed-meshheading:12847181-Phosphocreatine, pubmed-meshheading:12847181-Pilot Projects, pubmed-meshheading:12847181-Reference Values, pubmed-meshheading:12847181-Safety, pubmed-meshheading:12847181-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.
pubmed:affiliation
Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London, UK.
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial, Research Support, Non-U.S. Gov't